Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variations on a theme: the alternate translocations in APL.

R L Redner1

  • 1Department of Medicine, University of Pittsburgh, PA 15213, USA.

Leukemia
|October 3, 2002
PubMed
Summary

Variant translocations in acute promyelocytic leukemia (APL) are rare but offer crucial insights. Studying these genetic alterations, beyond the common PML-RAR fusion, enhances our understanding of APL pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dasatinib promotes ATRA-induced differentiation of AML cells.

Leukemia·2009
Same author

Gefitinib potentiates myeloid cell differentiation by ATRA.

Leukemia·2008
Same author

A novel t(3;17)(p25;q21) variant translocation of acute promyelocytic leukemia with rearrangement of the RARA locus.

Leukemia·2005
Same author

Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.

Oncogene·2005
Same author

The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.

Blood·2001
Same author

Involvement of the MLL and RARalpha genes in a patient with acute monocytic leukemia with t(11;17)(q23;q12)

Leukemia·2000

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • The t(15;17)(q22;q21) translocation, resulting in PML-RAR fusion, is the hallmark of acute promyelocytic leukemia (APL), found in 98% of cases.
  • While most variant translocations involve cryptic PML-RAR fusions, a few distinct genotypes have been identified in APL.
  • These variant genetic alterations are critical for understanding the molecular basis of APL.

Purpose of the Study:

  • To review and discuss rare variant translocations in acute promyelocytic leukemia.
  • To explore the genetic diversity of APL beyond the canonical PML-RAR fusion.
  • To highlight the insights gained from studying these variant genotypes.

Main Methods:

  • Review of scientific literature on APL genetics.
  • Analysis of reported cases with variant translocations.
  • Discussion of the molecular consequences of different fusion proteins.

Main Results:

  • Identification of variant translocations such as t(11;17)(q23;q21) producing PLZF-RAR, t(5;17)(q35;q21) forming NPM-RAR, t(11;17)(q13;q21) generating NUMA-RAR, and der(17) creating STAT5b-RAR.
  • Confirmation that most variant translocations represent cryptic PML-RAR fusions.
  • Demonstration of diverse genetic mechanisms underlying APL.

Conclusions:

  • Variant translocations, though rare, are important in APL.
  • Studying these diverse genetic events provides valuable insights into APL biology and potential therapeutic targets.
  • Understanding these genetic subtypes is crucial for comprehensive APL management.

Related Experiment Videos